Výsledky vyhledávání - "IL-5 receptor"

Akademický článek

Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

Autor: Pelaia C, Crimi C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta Jnr D, D'Amato M, Macchia L, Nolasco S, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Valenti G, Vatrella A, Crimi N

Publikováno v: Journal of Asthma and Allergy, Vol Volume 14, Pp 163-173 (2021)

Corrado Pelaia,1 Claudia Crimi,2 Alida Benfante,3 Maria Filomena Caiaffa,4 Cecilia Calabrese,5 Giovanna Elisiana Carpagnano,6 Domenico Ciotta Jnr,7 Maria D’Amato,8 Luigi Macchia,9 Santi Nolasco,2 Girolamo Pelaia,1 Simona Pellegrino,7 Nicola Scichil

Externí odkaz: https://doaj.org/article/60c44890e44b40cab8e2a69f7663a71f

Zobrazit plný text záznamu

Akademický článek

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series

Autor: Menzella F, Bonavia M, Bonini M, D'Amato M, Lombardo S, Murgia N, Patella V, Triggiani M, Pelaia G

Publikováno v: Journal of Asthma and Allergy, Vol Volume 14, Pp 149-161 (2021)

Francesco Menzella,1 Marco Bonavia,2 Matteo Bonini,3 Maria D’Amato,4 Salvatore Lombardo,5 Nicola Murgia,6 Vincenzo Patella,7,8 Massimo Triggiani,9 Girolamo Pelaia10 1Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS

Externí odkaz: https://doaj.org/article/865e7b48ba9149ee9935b54d7561d4c9

Zobrazit plný text záznamu

Akademický článek

Severe hypereosinophilic syndrome successfully treated with a monoclonal antibody against interleukin 5 receptor α – benralizumab

Autor: Joanna Kosałka-Węgiel, Mamert Milewski, Andżelika Siwiec, Magdalena Strach, Bogdan Ochrem, Mariusz Korkosz

Publikováno v: Central European Journal of Immunology, Vol 46, Iss 3, Pp 395-397 (2021)

Externí odkaz: https://doaj.org/article/051fb2e1f3c9435ea4318e84e0c92b0e

Zobrazit plný text záznamu

Akademický článek

Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity

Autor: Jung-Eun Kim, Dong-Hyun Lee, Keunok Jung, Eun-Ji Kim, Youngwoo Choi, Hae-Sim Park, Yong-Sung Kim

Publikováno v: Frontiers in Immunology, Vol 11 (2021)

Patients with severe eosinophilic asthma (SEA; characterized by persistent eosinophilia in blood and airway tissues) experience frequent asthma exacerbations with poor clinical outcomes. Interleukin 5 (IL-5) and IL-5 receptor alpha subunit (IL-5α) p

Externí odkaz: https://doaj.org/article/f09d89344684411aa1f4400a669e58b4

Zobrazit plný text záznamu

Akademický článek

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use

Autor: Maselli DJ, Rogers L, Peters JI

Publikováno v: Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 2059-2068 (2018)

Diego Jose Maselli,1 Linda Rogers,2 Jay I Peters1 1Division of Pulmonary Diseases and Critical Care, University of Texas Health, San Antonio, TX, USA; 2Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine Mount Sinai – Na

Externí odkaz: https://doaj.org/article/aee5e39e0ccd4b17845940b14ab2874b

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Benralizumab in the treatment of severe asthma: design, development and potential place in therapy

Autor: Pelaia C, Vatrella A, Bruni A, Terracciano R, Pelaia G

Publikováno v: Drug Design, Development and Therapy, Vol Volume 12, Pp 619-628 (2018)

Corrado Pelaia,1 Alessandro Vatrella,2 Andrea Bruni,1 Rosa Terracciano,3 Girolamo Pelaia1 1Department of Medical and Surgical Sciences, Section of Respiratory Diseases, “Magna Græcia” University of Catanzaro, Catanzaro, Italy; 2Department of Med

Externí odkaz: https://doaj.org/article/0fdadbda5b4a47ca99d7a0ae057a9ced

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání